Long-Cheng Li, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
li_long-cheng

Associate Professor In Residence, Department of Urology, UCSF

lilc@urology.ucsf.edu

Phone: (415) 476-3802 (voice)
Box 3110, UCSF
San Francisco, CA 94143-3110

View on UCSF Profiles


Additional Websites


Education

Tongji Medical University, China, MD, 1979-1984, Medicine
Tongji Medical University, China, MChir, 1988-1991, Surgery
Palermo University, Italy, Postdoc, 1997-1998, Urology
University of California, San Francisco, Postdoc, 1999-2001, Molecular Biology


Professional Experience

  • 1983 - 1984
    Intern, Medicine, Tongji Medical University (China)
  • 1984-1988
    Resident, Surgery and Urology, Shashi Second Hospital, Hubei (China)
  • 1989-1991
    Chief Resident, Urology, Tongji Medical University (China)
  • 1991-1996
    Attending Urologist, Tongji Medical University (China)
  • 2000 - 2001
    Bioinformatics Scientist, DoubleTwist, Inc., Oakland, CA
  • 2001 - 2006
    Research Scientist, Urology, Northern California Institute for Research and Education (NCIRE), SF VAMC
  • 2006-2007
    Assistant Researcher, Dept. of Urology, University of California San Francisco, San Francisco, CA
  • 2007-2010
    Assistant Adjunct Professor, Dept. of Urology, University of California San Francisco, San Francisco, CA
  • 2010-2011
    Assistant Professor, Dept. of Urology, University of California San Francisco, San Francisco, CA
  • 2010-2011
    Associate Professor in Residence, Dept. of Urology, University of California San Francisco, San Francisco, CA

Honors & Awards

  • 1997
    Société Internationale d'Urologie Fellowship

Selected Publications

  1. Wang C, Chen Z, Ge Q, Hu J, Li F, Hu J, Xu H, Ye Z, Li LC. Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells. FEBS Lett. 2014 Nov 11.
    View on PubMed
  2. Wang J, Huang V, Ye L, Bárcena A, Lin G, Lue TF, Li LC. Identification of Small Activating RNAs that Enhance Endogenous OCT4 Expression in Human Mesenchymal Stem Cells. Stem Cells Dev. 2014 Sep 18.
    View on PubMed
  3. Li G, Pan T, Guo D, Li LC. Regulatory Variants and Disease: The E-Cadherin -160C/A SNP as an Example. Mol Biol Int. 2014; 2014:967565.
    View on PubMed
  4. Jiao L, Deng Z, Xu C, Yu Y, Li Y, Yang C, Chen J, Liu Z, Huang G, Li LC, Sun Y. miR-663 Induces Castration-Resistant Prostate Cancer Transformation and Predicts Clinical Recurrence. J Cell Physiol. 2014 Jul; 229(7):834-44.
    View on PubMed
  5. Huang V, Li LC. Demystifying the nuclear function of Argonaute proteins. RNA Biol. 2014 Jan 1; 11(1):18-24.
    View on PubMed
  6. Li LC. Chromatin remodeling by the small RNA machinery in mammalian cells. Epigenetics. 2014 Jan 1; 9(1):45-52.
    View on PubMed
  7. Huang V, Zheng J, Qi Z, Wang J, Place RF, Yu J, Li H, Li LC. Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells. PLoS Genet. 2013; 9(9):e1003821.
    View on PubMed
  8. Ren S, Kang MR, Wang J, Huang V, Place RF, Sun Y, Li LC. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth. Prostate. 2013 Oct; 73(14):1591-601.
    View on PubMed
  9. Wang T, Li M, Yuan H, Zhan Y, Xu H, Wang S, Yang W, Liu J, Ye Z, Li LC. saRNA guided iNOS up-regulation improves erectile function of diabetic rats. J Urol. 2013 Aug; 190(2):790-8.
    View on PubMed
  10. Ahmed M, Li LC. Adaptation and clonal selection models of castration-resistant prostate cancer: current perspective. Int J Urol. 2013 Apr; 20(4):362-71.
    View on PubMed
  11. Kosaka M, Kang MR, Yang G, Li LC. Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells. Nucleic Acid Ther. 2012 Oct; 22(5):335-43.
    View on PubMed
  12. Kang MR, Yang G, Place RF, Charisse K, Epstein-Barash H, Manoharan M, Li LC. Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth. Cancer Res. 2012 Oct 1; 72(19):5069-79.
    View on PubMed
  13. Kang MR, Yang G, Charisse K, Epstein-Barash H, Manoharan M, Li LC. An orthotopic bladder tumor model and the evaluation of intravesical saRNA treatment. J Vis Exp. 2012; (65).
    View on PubMed
  14. Wang X, Wang J, Huang V, Place RF, Li LC. Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. Biochem J. 2012 May 1; 443(3):821-8.
    View on PubMed
  15. Place RF, Wang J, Noonan EJ, Meyers R, Manoharan M, Charisse K, Duncan R, Huang V, Wang X, Li LC. Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression. Mol Ther Nucleic Acids. 2012; 1:e15.
    View on PubMed
  16. Huang V, Li LC. miRNA goes nuclear. RNA Biol. 2012 Mar; 9(3):269-73.
    View on PubMed
  17. Wang J, Li LC. Small RNA and its application in andrology and urology. Transl Androl Urol. 2012; 1(1):33-43.
    View on PubMed
  18. Huang V, Place RF, Portnoy V, Wang J, Qi Z, Jia Z, Yu A, Shuman M, Yu J, Li LC. Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res. 2012 Feb; 40(4):1695-707.
    View on PubMed
  19. Portnoy V, Huang V, Place RF, Li LC. Small RNA and transcriptional upregulation. Wiley Interdiscip Rev RNA. 2011 Sep-Oct; 2(5):748-60.
    View on PubMed
  20. Wang J, Place RF, Huang V, Wang X, Noonan EJ, Magyar CE, Huang J, Li LC. Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res. 2010 Dec 15; 70(24):10182-91.
    View on PubMed

Go to UCSF Profiles, powered by CTSI